2022
DOI: 10.3390/ph15050571
|View full text |Cite
|
Sign up to set email alerts
|

Radiotracers for the Central Serotoninergic System

Abstract: This review lists the most important radiotracers described so far for imaging the central serotoninergic system. Single-photon emission computed tomography and positron emission tomography radiotracers are reviewed and critically discussed for each receptor.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
2
1

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 298 publications
(302 reference statements)
0
2
0
Order By: Relevance
“…Similarly, agonists at the 5-HT2A receptor seem to label fewer binding sites than antagonists in transfected cells and are more potent in displacing agonist tracers than antagonist tracers at 5-HT2A [98], consistent with the receptor model in Figure 1. In addition, only agonist but not antagonist tracers can be detectably affected by competing levels of endogenous agonist ligands, demonstrated with serotonin in vivo load and 5-HT2A imaging with an agonist and antagonist tracer [97]. Distinct binding properties of agonists and antagonists are consistent with ligand-free R* signaling, yielding distinct in vivo labeling patterns as indicators of ligand-free R* signaling.…”
Section: Relevance Of Ligand-free R* Signaling To In Vivo Receptor Im...mentioning
confidence: 98%
See 1 more Smart Citation
“…Similarly, agonists at the 5-HT2A receptor seem to label fewer binding sites than antagonists in transfected cells and are more potent in displacing agonist tracers than antagonist tracers at 5-HT2A [98], consistent with the receptor model in Figure 1. In addition, only agonist but not antagonist tracers can be detectably affected by competing levels of endogenous agonist ligands, demonstrated with serotonin in vivo load and 5-HT2A imaging with an agonist and antagonist tracer [97]. Distinct binding properties of agonists and antagonists are consistent with ligand-free R* signaling, yielding distinct in vivo labeling patterns as indicators of ligand-free R* signaling.…”
Section: Relevance Of Ligand-free R* Signaling To In Vivo Receptor Im...mentioning
confidence: 98%
“…For the interpretation of imaging studies of GPCRs with potent labeled ligands [96], the receptor model can serve to dissect agonist and antagonist binding profiles in vivo. For accurate positron emission tomography (PET) imaging of neurotransmitter receptors, for example serotonin receptors [97], a large portion of high affinity tracers present in the brain must reside at receptor sites to attain clear images. This phenomenon can result from selective retention in a receptor domain because of a diffusion boundary (for example the synaptic cleft) that slows ligand dispersal (Figure 3) [66].…”
Section: Relevance Of Ligand-free R* Signaling To In Vivo Receptor Im...mentioning
confidence: 99%